Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.
about
Emerging concepts in the immunopathogenesis of AIDSChallenges in mucosal HIV vaccine development: lessons from non-human primate modelsTCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in Mamu-A*01+ rhesus monkeysSang Froid in a time of trouble: is a vaccine against HIV possible?Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized TrialImmunity to HIV-1 is influenced by continued natural exposure to exogenous virus.Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical statusInsertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigensImpact of highly active antiretroviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa.HIV Infection and Gut Mucosal Immune Function: Updates on Pathogenesis with Implications for Management and Intervention.Mucosal T-cell responses to HIV: responding at the front linesCorrelating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers.Immune responses to HIV and SIV in mucosal tissues: 'location, location, location'.Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapyEffect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapyHIV infection and the gastrointestinal immune systemComparative analysis of measures of viral reservoirs in HIV-1 eradication studiesImmune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implicationsA randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers.CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals.Cryopreservation of Human Mucosal Leukocytes.Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection.Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infectionDifferential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.Mucosal immunity to HIV: a review of recent literature.Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.HIV/AIDS vaccines: a need for new concepts?Development and use of SIV-based Integrase defective lentiviral vector for immunization.High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage.Phenotype and functionality of CD4+ and CD8+ T cells in the upper reproductive tract of healthy premenopausal women.Assessment of mucosal immunity to HIV-1.Mucosal immunity in HIV controllers: the right place at the right time.Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity?Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.Aging, cytomegalovirus (CMV) and influenza vaccine responses.Enhancing efficacy and mucosa-tropic distribution of an oral HIV-PsV DNA vaccine in animal models.Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy
P2860
Q22241984-F13C0E84-516C-445F-B339-0B528E329F9EQ27022152-C7CDA41F-B548-4394-A032-DDAFD9F0B845Q27329011-6976BB4C-D114-46AB-AEF1-F78641762444Q27487961-70C0562B-A9A6-47E7-9DB4-C52D68236238Q28552729-8285BEE6-A576-4CD6-A9BA-7A8235BB9592Q33379075-95F7E33E-0A33-4ACA-9C02-AF1209D6620CQ33381538-426ABB08-EE15-45C9-9DE7-807EC5358732Q33627613-059AA548-44D8-4CA0-A370-A36C330EA605Q33631238-862AAF6E-DF40-40FA-9F63-B598F4EBDD92Q33651723-EDA1F129-B0CC-4408-BAC3-9F1114B50CA4Q33681946-89630100-AE04-473E-86DA-44E278EAB556Q33805995-9C504F7A-A910-421D-B2B3-93F0429820E6Q33915790-287DE8AE-6F07-4E61-8650-DE9EED0D647FQ34120763-58EEFE41-D56E-4F0D-93C7-42F47FD5FC9EQ34384134-EFF3336A-AB88-4054-8584-89534F22C8F5Q34384143-C0BB9706-24D0-4BB1-9713-150BFF288DB6Q34601874-BD707B8B-1310-45CD-BE18-8C3FB7749E88Q34607763-9AE066F0-B71A-4D7D-A155-CB7702EB9454Q34712244-8478F7D6-6F03-4075-AD50-090EF8D5502EQ34743336-7C01465B-BE4B-4CB1-9593-341CC2B7FABDQ35018065-3A92D1D8-709B-4306-8EAB-04E48133A785Q35095403-B82E6FF6-E337-4B7C-91D1-D787449ED085Q36032572-6B99282A-A8C5-4134-8D72-7600170E3ABCQ36747697-386ABEE2-AAFF-40F3-8CA5-C85AAB73A93EQ36845972-9770C47B-64BE-4F66-BEDC-51C7365600F1Q36915902-D0133EA8-A3B3-4A38-85CA-7EB1592F8428Q37137068-E16BFD0B-0964-4658-9429-50EAB56D8D79Q37169129-9F0AF04B-3237-49DD-970F-D512D2F128BFQ37262446-25FA524D-7A8A-46B6-A9AB-F2565B639A7BQ37344236-468BE48A-02F0-43B6-A476-A9CE0F7F5A21Q37369322-6558C395-4477-46B2-8C21-3B11557C94C2Q37421578-08C064B8-5B5D-45E5-9ECB-B0ECD7457FBEQ37626039-C6162B79-608E-4301-967C-E913EA2F1850Q37724856-96AC22C5-5DD7-4055-9F85-51F1B4ACE35FQ37852547-E5B00FCF-C838-4722-ADE4-04BB5CE56EC3Q38038756-1CC07275-B3D3-46A7-A791-3F408CB8ABDEQ38098176-3B93D941-4F52-43BE-9160-D0A02760AE51Q38640148-4D08198B-30E2-43B4-BC04-BB84E03342B5Q39013219-D1F91690-5BBD-4607-9384-035CA9788DC7Q39048479-D6D35C58-8292-40AC-A02C-36483AE1BCCD
P2860
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Multifunctional human immunode ...... chronic HIV type 1 infection.
@ast
Multifunctional human immunode ...... chronic HIV type 1 infection.
@en
type
label
Multifunctional human immunode ...... chronic HIV type 1 infection.
@ast
Multifunctional human immunode ...... chronic HIV type 1 infection.
@en
prefLabel
Multifunctional human immunode ...... chronic HIV type 1 infection.
@ast
Multifunctional human immunode ...... chronic HIV type 1 infection.
@en
P2093
P2860
P356
P1433
P1476
Multifunctional human immunode ...... g chronic HIV type 1 infection
@en
P2093
David M Asmuth
Digna H Walker
Donna Lemongello
J William Critchfield
Juan C Garcia
Richard B Pollard
P2860
P304
P356
10.1128/JVI.02535-06
P407
P577
2007-03-07T00:00:00Z